Disabled World News

FAMPYR Now Available in Canada for Improvement of Walking in MS

Thu, 12 Apr 2012 11:26:16 EST

FAMPYR(R), the First Oral Treatment for the Improvement of Walking in MS, is Now Available in Canada.

Significant Symptom Relief in MS Patients Seen by Interventional Radiologists

Tue, 27 Mar 2012 10:01:17 EST

Short-term Follow-up Supports Evidence That Angioplasty of Azygos and Jugular Veins Safe, Improves Quality of Life for Those With Multiple Sclerosis, Say Researchers at Society of Interventional Radiology's 37th Annual Scientific Meeting.

Celiac Disease - Depression and Disordered Eating in Women

Tue, 27 Dec 2011 13:24:49 EST

We found that most participants frequently adhered to a gluten-free diet, and this greater compliance with diet was related to increased vitality, lower stress, decreased depressive symptoms and greater overall emotional health.

Rheumatoid Arthritis - Cheaper Medication Works for Newly Diagnosed Patients

Mon, 14 Nov 2011 11:22:01 EST

One of the largest clinical studies ever done in rheumatoid arthritis has determined that a large number of patients do well on lower cost treatments.

Pregnancy Safe for 80% of Women with Lupus

Sun, 06 Nov 2011 14:06:33 EST

Most women with lupus can have successful pregnancy outcomes - Results from multicenter NIH PROMISSE study find pregnancy safe for 80 percent of women with lupus.

Major Breakthrough in Multiple Sclerosis Found Using Upright MRI

Thu, 06 Oct 2011 09:19:15 EST

Major Diagnostic Breakthrough in Multiple Sclerosis
Achieved With Advanced UPRIGHT MRI.

Survey of Rheumatologists Reveals Health Insurance Barriers Jeopardize Ability of Physicians to Effectively Treat Patients

Sun, 02 Oct 2011 12:39:17 EST

CSRO Survey of Rheumatologists Nationwide Reveals Health Insurance Barriers Jeopardize Patient Access to Care and Ability of Physicians to Effectively Treat Patients.

P21 Protein Halts Rheumatoid Arthritis

Thu, 08 Sep 2011 09:38:26 EST

New bouncer molecule halts rheumatoid arthritis - Protective protein prevents immune system from ravaging joints and bones.

Breakthrough in Search for Multiple Sclerosis Treatment

Thu, 30 Jun 2011 17:53:53 EST

Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) - a chronic inflammatory disease of the central nervous system.

Osteoarthritis Incidence Higher Among Military Personnel

Wed, 29 Jun 2011 18:05:34 EST

Osteoarthritis incidence significantly higher among US military personnel compared to general population.

Minimally Invasive Treatment for MS Patients

Thu, 23 Jun 2011 13:38:34 EST

SIR Foundation sets research priorities for minimally invasive treatments for MS patients.

Shingles May be Related to Elevated Risk of Multiple Sclerosis

Sun, 12 Jun 2011 13:14:07 EST

There is epidemiological evidence that some herpes viruses may contribute to multiple sclerosis (MS) occurrence.

Link Between COPD and Rheumatoid Arthritis Confirmed

Thu, 26 May 2011 11:04:27 EST

Study confirms link between rheumatoid arthritis and COPD - COPD prevalence twice as high in patients with RA.

Inability to Cry - Sjogrens Syndrome

Thu, 26 May 2011 10:12:32 EST

Inability to cry in patients with Sjogrens syndrome affect emotional and mental well-being.

Viagra May Reduce MS Symptoms

Thu, 19 May 2011 10:21:01 EST

Universitat Autonoma de Barcelona researchers have discovered that Viagra drastically reduces multiple sclerosis symptoms in animal models with the disease.

Cimzia (Certolizumab Pegol) Shows Rapid Relief From Rheumatoid Arthritis Symptoms

Thu, 12 May 2011 11:12:41 EST

Cimzia(R) (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients.

Chronic Ulcerative Stomatitis an Autoimmune Disease

Mon, 18 Apr 2011 11:22:16 EST

New Evidence that Chronic Ulcerative Stomatitis is an Autoimmune Disease.

Compound Effectively Halts Progression of Multiple Sclerosis

Mon, 18 Apr 2011 10:58:17 EST

Scientists develop compound that effectively halts progression of multiple sclerosis - The discovery also holds promise for other autoimmune disorders.

Disability Timeline for Progressive MS

Fri, 15 Apr 2011 08:40:38 EST

Mayo Clinic Finds Tool to Predict Disability Timeline for Progressive MS Patients.

Novartis Therapy GilenyaTM Reduced Risk of MS Disability Progression

Mon, 11 Apr 2011 10:55:14 EST

Novartis therapy GilenyaTM reduced the risk of MS disability progression regardless of treatment history or disease severity, new analysis shows.